Table 1.

The basic information of prostate cancer (PCa) and non-PCa in men.

Basic information	PCa men		Non-PCa men		t	P
	n	$\overline{X}\pm \text{s}$	n	$\overline{X}\pm \text{s}$
Age	107	68.25 ± 7.09	177	68.97 ± 7.75	3.63	0.58
TPSA	107	27.41 ± 3.34	177	15.26 ± 3.27	5.06	0.001
FPSA	107	3.13 ± 0.55	177	2.09 ± 1.03	2.78	0.006
FPSA/TPSA	107	0.12 ± 0.07	177	0.15 ± 0.08	−3.62	0.001
WBC	107	6.83 ± 2.32	177	6.38 ± 2.55	1.48	0.14
Neutrophil	107	4.51 ± 2.19	177	4.12 ± 2.27	1.39	0.17
Lymphocyte	107	1.69 ± 0.54	177	1.64 ± 0.59	0.77	0.44
Monocyte	107	0.47 ± 0.19	177	0.46 ± 0.23	0.35	0.73
Platelet	107	232.22 ± 67.59	177	217.97 ± 69.81	1.69	0.09
Eosnophils	107	0.14 ± 0.03	177	0.14 ± 0.02	0.29	0.77
Basophils	107	0.03 ± 0.01	177	0.03 ± 0.01	1.09	0.27
MPV	107	9.06 ± 1.07	177	9.41 ± 1.11	−2.63	0.009
PDW	107	15.43 ± 1.87	177	14.79 ± 2.32	2.45	0.015

Comparisons were made by t-test. There is a statistical difference in free prostate-specific antigen (FPSA), total PSA (TPSA), FPSA/TPSA, mean platelet volume (MPV), and platelet distribution width (PDW).